Description
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
Cas No. | 639052-78-1 |
---|---|
Purity | ≥98% |
Formula | C16H13ClN2OS |
Formula Wt. | 316.80 |
IUPAC Name | N-(5-Chloro-6-methyl-1,3-benzothiazol-2-yl)-2-phenylacetamide |
Solubility | 100mM in DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Lee JW, Hirota T, Peters EC, et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10608-11. PMID: 21954091.
Semi-synthetic avermectin; GABA potentiator.
Inhibitor of Monoacyglycerol lipase (MAGL).
p110δ PI3K inhibitor.
CID-797718 analog; potential PKD1 binding agent...
Inert clozapine analog, activates specialized G...
Coumarin; VKORC1 inhibitor.
Rifamycin derivative, induces pore formation in...
Akt inhibitor.
Peptide, protease substrate.
Non-endogenous essential amino acid found in me...
Endogenous bile acid; FXR agonist.
NSAID; COX-1/2 inhibitor.
Avermectin; glu-gated Cl- channel activator, Gl...
B-Raf inhibitor.
O-methylated coumarin; Ca2+ channel blocker.
Diterpene originally found in Rabdosia.
Neurotoxin, mutagen.
CHK1 inhibitor.
Semi-synthetic avermectin; GABA potentiator.